Galectin-3 predicts the risk of ventricular tachycardia in ischemic heart failure patients with implantable cardioverter-defibrillator
30 June 2021 (14:00 - 15:00)
Organised by:
About the speaker
Cardiology Research Institute, Tomsk National Research Medical Centre of Russian Academy of Science, Tomsk (Russian Federation)
9 More presentations in this session
Doctor C. Lam (Singapore, SG)
Access the full session
The Event
Heart Failure 2021
30 June 2021
14:00 CET
You may be interested in
Congress Presentation
Congress Session
